Melittin kills A549 cells by targeting mitochondria and blocking mitophagy flux

References

• Kocarnik JM, Compton K, Dean FE, et al. Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the global burden of disease study 2019. JAMA Oncol. 2022;8:420–444. doi:10.1001/jamaoncol.2021.6987
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Laversanne M, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Howlader N, Forjaz G, Mooradian MJ, et al. The effect of advances in lung-cancer treatment on population mortality. N Engl J Med. 2020;383:640–649. doi:10.1056/NEJMoa1916623
   PubMed Web of Science ®Google Scholar
• Seguin L, Durandy M, Feral CC. Lung adenocarcinoma tumor origin: a guide for personalized medicine. Cancers (Basel). 2022;14. doi:10.3390/cancers14071759
   PubMed Web of Science ®Google Scholar
• Tian Y, Xu L, Li X, et al. SMARCA4: current status and future perspectives in non-small-cell lung cancer. Cancer Lett. 2023;554(Feb 1):216022. doi:10.1016/j.canlet.2022.216022
   PubMedGoogle Scholar
• Wang A, Zheng Y, Zhu W, et al. Melittin-based nano-delivery systems for cancer therapy. Biomolecules. 2022;12(1):118. doi:10.3390/biom12010118
   PubMed Web of Science ®Google Scholar
• Ertilav K, Nazıroğlu M. Honey bee venom melittin increases the oxidant activity of cisplatin and kills human glioblastoma cells by stimulating the TRPM2 channel. Toxicon. 2023;222:106993. doi:10.1016/j.toxicon.2022.106993
   PubMed Web of Science ®Google Scholar
• Daniluk K, Lange A, Wójcik B, et al. Effect of melittin complexes with graphene and graphene oxide on triple-negative breast cancer tumors grown on chicken embryo chorioallantoic membrane. Int J Mol Sci. 2023;24. doi:10.3390/ijms24098388
   PubMed Web of Science ®Google Scholar
• Jeong C, Kim J, Han IH, et al. Melittin derived peptide-drug conjugate, M-DM1, inhibits tumor progression and induces effector cell infiltration in melanoma by targeting M2 tumor-associated macrophages. Front Immunol. 2023;14:1178776. doi:10.3389/fimmu.2023.1178776
   PubMedGoogle Scholar
• Li X, Zhu S, Li Z, et al. Melittin induces ferroptosis and ER stress-CHOP-mediated apoptosis in A549 cells. Free Radic Res. 2022;56:398–410. doi:10.1080/10715762.2022.2131551
   PubMed Web of Science ®Google Scholar
• Tang JLY, Moonshi SS, Ta HT. Nanoceria: an innovative strategy for cancer treatment. Cell Mol Life Sci. 2023;80:46. doi:10.1007/s00018-023-04694-y
   PubMed Web of Science ®Google Scholar
• Perillo B, Di Donato M, Pezone A, et al. ROS in cancer therapy: the bright side of the moon. Exp Mol Med. 2020;52:192–203. doi:10.1038/s12276-020-0384-2
   PubMed Web of Science ®Google Scholar
• Moloney JN, Cotter TG. ROS signalling in the biology of cancer. Semin Cell Dev Biol. 2018;80:50–64. doi:10.1016/j.semcdb.2017.05.023
   PubMed Web of Science ®Google Scholar
• Zhu S, Li X, Wu F, et al. Blue light induces skin apoptosis and degeneration through activation of the endoplasmic reticulum stress-autophagy apoptosis axis: protective role of hydrogen sulfide. J Photochem Photobiol B. 2022;229:112426. doi:10.1016/j.jphotobiol.2022.112426
   PubMed Web of Science ®Google Scholar
• Murray AJ, Horscroft JA. Mitochondrial function at extreme high altitude. J Physiol. 2016;594:1137–1149. doi:10.1113/JP270079
   PubMed Web of Science ®Google Scholar
• Pernas L, Scorrano L. Mito-Morphosis: mitochondrial fusion, fission, and cristae remodeling as key mediators of cellular function. Annu Rev Physiol. 2016;78:505–531. doi:10.1146/annurev-physiol-021115-105011
   PubMed Web of Science ®Google Scholar
• Wang Y, Chi H, Xu F, et al. Cadmium chloride-induced apoptosis of HK-2 cells via interfering with mitochondrial respiratory chain. Ecotoxicol Environ Saf. 2022;236:113494. doi:10.1016/j.ecoenv.2022.113494
   PubMed Web of Science ®Google Scholar
• Yaqoob MD, Xu L, Li C, et al. Targeting mitochondria for cancer photodynamic therapy. Photodiagnosis Photodyn Ther. 2022;38:102830. doi:10.1016/j.pdpdt.2022.102830
   PubMed Web of Science ®Google Scholar
• Geng Y, Xiang J, Shao S, et al. Mitochondria-targeted polymer-celastrol conjugate with enhanced anticancer efficacy. J Control Release. 2022;342:122–133. doi:10.1016/j.jconrel.2022.01.002
   PubMed Web of Science ®Google Scholar
• Zhang YM, Xia M, Ao R, et al. Smart design of mitochondria-targeted and ROS-responsive CPI-613 delivery nanoplatform for bioenergetic pancreatic cancer therapy. Nanomaterials (Basel). 2021;11.
   Google Scholar
• Capeloa T, Krzystyniak, d'Hose, et al. Mitoq inhibits human breast cancer cell migration, invasion and clonogenicity. Cancers (Basel). 2022;Mar 16;14(6):1516. doi:10.3390/cancers14061516
   Web of Science ®Google Scholar
• Kalyanaraman B. Exploiting the tumor immune microenvironment and immunometabolism using mitochondria-targeted drugs: challenges and opportunities in racial disparity and cancer outcome research. Faseb j. 2022;36:e22226. doi:10.1096/fj.202101862R
   PubMed Web of Science ®Google Scholar
• Luo Z, Gao Y, Duan Z, et al. Mitochondria-targeted self-assembly of peptide-based nanomaterials. Front Bioeng Biotechnol. 2021;9:782234. doi:10.3389/fbioe.2021.782234
   PubMed Web of Science ®Google Scholar
• Denisenko TV, Gogvadze V, Zhivotovsky B. Mitophagy in carcinogenesis and cancer treatment. Discov Oncol. 2021;12:58. doi:10.1007/s12672-021-00454-1
   PubMedGoogle Scholar
• Szczepanowska K, Trifunovic A. Tune instead of destroy: how proteolysis keeps OXPHOS in shape. Biochim Biophys Acta Bioenerg. 2021;1862:148365. doi:10.1016/j.bbabio.2020.148365
   PubMed Web of Science ®Google Scholar
• Qiu YH, Zhang TS, Wang XW, et al. Mitochondria autophagy: a potential target for cancer therapy. J Drug Target. 2021;29:576–591. doi:10.1080/1061186X.2020.1867992
   PubMed Web of Science ®Google Scholar
• Song J, Huang S, Zhang Z, et al. SPA: a peptide antagonist that acts as a cell-penetrating peptide for drug delivery. Drug Deliv. 2020;27:91–99. doi:10.1080/10717544.2019.1706669
   PubMed Web of Science ®Google Scholar
• Zhu S, Li X, Dang B, et al. Lycium Barbarum polysaccharide protects HaCaT cells from PM2.5-induced apoptosis via inhibiting oxidative stress, ER stress and autophagy. Redox Rep. 2022;27:32–44. doi:10.1080/13510002.2022.2036507
   PubMed Web of Science ®Google Scholar
• Kleinschmidt JH, Mahaney JE, Thomas DD, et al. Interaction of bee venom melittin with zwitterionic and negatively charged phospholipid bilayers: a spin-label electron spin resonance study. Biophys J. 1997;72:767–778. doi:10.1016/S0006-3495(97)78711-3
   PubMed Web of Science ®Google Scholar
• Ridgway Z, Picciano AL, Gosavi PM, et al. Functional characterization of a melittin analog containing a non-natural tryptophan analog. Biopolymers. 2015;104:384–394. doi:10.1002/bip.22624
   PubMed Web of Science ®Google Scholar
• Yu R, Wang M, Wang M, et al. Melittin suppresses growth and induces apoptosis of non-small-cell lung cancer cells via down-regulation of TGF-β-mediated ERK signal pathway. Braz J Med Biol Res. 2020;54:e9017. doi:10.1590/1414-431x20209017
   PubMed Web of Science ®Google Scholar
• Kong GM, Tao WH, Diao YL, et al. Melittin induces human gastric cancer cell apoptosis via activation of mitochondrial pathway. World J Gastroenterol. 2016;22:3186–3195. doi:10.3748/wjg.v22.i11.3186
   PubMed Web of Science ®Google Scholar